You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Immunodeficiency 36 with lymphoproliferation, look for clinical trials, and connect with others living with it — all in one place.
Open the full Immunodeficiency 36 with lymphoproliferation hub →Immunodeficiency 36 with lymphoproliferation is a rare condition. Also known as APDS type 2, APDS2, Activated p110delta syndrome, type 2, Activated phosphoinositide 3-kinase delta syndrome type 2, PASLI-R1, Senescent T-cells-lymphadenopathy-immunodeficiency syndrome due to p110delta-activating mutations, type 2. Tomeko brings together the specialists, research, clinical trials, treatments and community for Immunodeficiency 36 with lymphoproliferation so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:693681 · OMIM 616005 · ICD-10 D81.8 · GARD 0016046
Start by learning the basics from an authoritative source, find a specialist or center that sees Immunodeficiency 36 with lymphoproliferation, and connect with a patient organization. Tomeko brings these together on one hub.
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Immunodeficiency 36 with lymphoproliferation, filtered to your area.
Tomeko shows live, recruiting studies for Immunodeficiency 36 with lymphoproliferation from ClinicalTrials.gov on the hub.